September 2021 - Patrick Anquetil sat down with ASAP Biopharma ahead of his keynote "Alliance Managers Are Bringing Digital Health Innovation" which is slated for 10:20 a.m. EDT on September 28th. The keynote will be followed by a Q&A session.
Patrick Anquetil, PhD, MBA sat down with ASAP Biopharma ahead of his keynote “Alliance Managers Are Bringing Digital Health Innovation” which is slated for 10:20 a.m. EDT on September 28th. Dr. Anquetil will reveal how Portal’s alliance governance, framework, and execution are inextricably linked to the advancement of this groundbreaking drug-delivery mechanism. After the keynote Dr. Anquetil plans to have a Q&A session and discussion of any aspect of innovation that isn’t covered in his presentation, including but not limited to issues related to regulatory, manufacturing, and commercial phases of the drug development life cycle.
Read the full interview here: ASAP BioPharma Conference Keynote Preview: Alliance Managers Are Bringing Digital Health Innovation
August 29, 2024 - Patrick Anquetil talks with Ryan Cote on the Manufacturer's Mindset Podcast. They discuss insights, challenges, and the lessons learned on the journey of revolutionizing needle-free injections at Portal Instruments.
Today Portal Instruments announced a joint publication with Regeneron on the PRIME needle-free injection platform. The findings provided crucial data on Portal's platform, demonstrating the ability to deliver high-viscosity biologics with volume flexibility and tailored injection depths.
March 2024 - Portal Instruments is pleased to be returning to Dana Point, California to share its drug delivery technology with investors and other emerging medtech companies at LSI USA '24. Patrick Anquetil, CEO, will be presenting the updates.
Please fill out the details below and we will get back to you shortly.